The New Path to ADCs
March 24, 2026
Engineering payload selectivity for a better quality of life
9 min read
False
March 24, 2026
Engineering payload selectivity for a better quality of life
9 min read
March 17, 2026
Preclinical study shows saRNA therapy improved cardiac function and reduced infarct size after myocardial infarction
1 min read
March 17, 2026
UCLA researchers create armored CAR-T cells that show promise for treating solid tumors
2 min read
March 16, 2026
An optimized workflow increases lentiviral delivery efficiency for large CAR constructs
1 min read
March 16, 2026
The first-in-human ATLAS trial will test PRAME-targeting CRISPR T cells in advanced cancers
2 min read
March 13, 2026
Modified APOBEC3G editors improve CRISPR base-editing specificity and reduce bystander mutations in human cells
2 min read
March 12, 2026
ReiThera’s leaders discuss platform technologies, scalable manufacturing, and the trust needed to strengthen global vaccine preparedness
5 min read
By Pete Harbin
March 12, 2026
Why therapies still take years to reach the patients who need them
4 min read
March 9, 2026
CRISPR editing removes PGE2 receptors from therapeutic T cells, improving persistence and tumor control in preclinical models
2 min read
March 4, 2026
Preclinical findings suggest that receptor design and timed kinase inhibition could help strengthen next-generation cell therapies.
1 min read
False
False
False